Migratory CD103

Foxp3 IgA Peyer’s patches cholera toxin classical dendritic cells follicular helper T cells oral immunization peripherally induced regulatory T cells

Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 26 07 2023
revised: 06 03 2024
accepted: 07 03 2024
medline: 17 3 2024
pubmed: 17 3 2024
entrez: 16 3 2024
Statut: aheadofprint

Résumé

Induction and regulation of specific intestinal IgA responses critically depend on dendritic cell subsets and the T cells they activate in the Peyer's patches (PP). We found that oral immunization with cholera toxin (CT) as an adjuvant resulted in migration-dependent changes in the composition and localization of PP DC subsets with increased numbers of CD103

Identifiants

pubmed: 38492746
pii: S1933-0219(24)00023-0
doi: 10.1016/j.mucimm.2024.03.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Inta Gribonika (I)

Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: inta.gribonika@nih.gov.

Anneli Strömberg (A)

Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Rakesh K Chandode (RK)

Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Karin Schön (K)

Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Katharina Lahl (K)

Immunology Section, Lund University, BMC D14, 221 84 Lund, Sweden; Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Mats Bemark (M)

Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Translational Medicine - Human Immunology, Lund University, J Waldenströms gata 35, 205 02 Malmö, Sweden. Electronic address: mats.bemark@med.lu.se.

Nils Lycke (N)

Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Classifications MeSH